What the Research Says
Ulven et al. (2011) compared 3 g/day krill oil supplying 543 mg EPA+DHA with 1.8 g/day fish oil supplying 864 mg EPA+DHA, and a no-supplement group, in 113 adults. Both oils increased plasma omega-3 levels, with no significant between-oil difference. Serum lipids and inflammatory markers did not significantly differ among groups. The study did not demonstrate 68% greater red-cell incorporation at matched doses.
A 2020 network meta-analysis of 64 trials found no significant lipid-effect difference between krill and fish oil; triglyceride reduction depended on omega-3 dose. Other krill-oil reviews report some lipid changes, but laboratory lipid changes do not prove fewer cardiovascular events.
A small PMS trial compared krill oil with fish oil, without placebo. Joint-outcome reviews have mixed findings. These condition-specific results do not establish a universal 1–3 g therapeutic regimen or clinical superiority from the phospholipid form.




